Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
APPROVALS
APPROVALS
APPROVALS
Xenpozyme (olipudase alfa) approved by European Commission as first treatment for ASMD
Tess Egginton
-
4th July 2022
0
APPROVALS
European Commission approves Kite’s CAR T-cell therapy Yescarta to treat relapsed or refractory follicular lymphoma
Tess Egginton
-
29th June 2022
0
APPROVALS
Cosentyx (secukinumab) receives expanded approvals in EU for use in childhood arthritic conditions
Tess Egginton
-
27th June 2022
0
APPROVALS
MHLW in Japan grants approval for BioMarin’s Voxzogo for children with achondroplasia
Tess Egginton
-
23rd June 2022
0
APPROVALS
Novartis receives European Commission approval for lung cancer drug
Tess Egginton
-
23rd June 2022
0
APPROVALS
Amylyx Pharmaceuticals receives Health Canada approval for ALBRIOZA for the treatment of ALS
Tess Egginton
-
15th June 2022
0
APPROVALS
China NMPA approves tislelizumab for recurrent or metastatic nasopharyngeal cancer
Tess Egginton
-
14th June 2022
0
APPROVALS
FDA approves first systemic treatment for alopecia areata
Tess Egginton
-
14th June 2022
0
APPROVALS
Everest Medicines’ Trodelvy gains approval in China for second-line metastatic triple-negative breast cancer
Tess Egginton
-
13th June 2022
0
APPROVALS
US FDA approves GSK’s Priorix for the prevention of measles, mumps and rubella in individuals 12 months of age and older
Tess Egginton
-
8th June 2022
0
1
2
3
...
10
Page 1 of 10
